You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
3 June 2026 - Clinical-stage biopharmaceutical company Arcus Biosciences Inc (NYSE:RCUS) announced on Wednesday that it has entered into a clinical trial collaboration and supply agreement with biopharmaceutical company Bristol Myers Squibb (BMS) (NY...
3 June 2026 - Computational chemistry company Evogene Ltd (Nasdaq:EVGN) (TASE:EVGN) announced on Tuesday the successful completion of the first-in-human (FIH) Phase 1 clinical study of BMC128, a rationally-designed live bacterial product developed by...
3 June 2026 - Specialty pharmaceutical company Cumberland Pharmaceuticals Inc (Nasdaq:CPIX) and healthcare provider Vanderbilt Health on Tuesday announced data from a Phase 2a clinical trial of ifetroban to prevent metastasis in high-risk solid tumou...
3 June 2026 - Creatv Bio, a division of Creatv MicroTech Inc, a liquid biopsy company focused on innovative diagnostics for cancer, and Neovia Oncology LLC, a pharmaceutical company developing novel oncology therapies, announced on Tuesday the signin...
2 June 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Tuesday that the US Food and Drug Administration (FDA) has accepted its New Drug Application under Priority Review for giredestrant as a...
2 June 2026 - Biopharmaceutical company UCB (EBR:UCB) announced on Monday the launch of the inaugural UCB Hidradenitis Suppurativa Scholarship Program.This program is designed to support adults age 18 and older living with hidradenitis suppurativa (H...